• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

The Top 5 Biosimilar Articles for the Week of May 16

Video

Here are the top 5 biosimilar articles for the week of May 16, 2022.

Hi, I’m Skylar Jeremias for The Center for Biosimilars®, your resource for clinical, regulatory, business, and policy news in the rapidly changing world of biosimilars.

Here are the top 5 biosimilar articles for the week of May 16, 2022.

Number 5: Posters from the Academy of Managed Care Pharmacy (AMCP)’s annual meeting examined the real-world patterns of biosimilar utilization and the impact of products that have been reclassified as biologics on Medicaid spending.

Number 4: A new bill that would amend the Federal Food, Drug, and Cosmetic Act aims to expand FDA user fee programs for prescription drugs and medical devices, including biosimilars and generics.

Number 3: Biocon’s total revenue for the fourth quarter of the 2022 fiscal year was up 21% from the same period in the prior year, largely due to significant growth in sales for the company’s biosimilar and generic drugs.

Number 2: The United Kingdom has approved Teva Pharmaceutical’s biosimilar (Ongavia), which references Lucentis (ranibizumab), for the treatment of several ophthalmic conditions.

Number 1: In a pharmacokinetic study, Alvotech’s ustekinumab biosimilar referencing Stelara was shown to have comparable safety and efficacy to the reference product, according to the company’s preliminary results.

To read all of these articles and more, visit centerforbiosimilars.com.

Recent Videos
Here are the top 5 biosimilar articles for the week of March 24, 2025.
Here are the top 5 biosimilar articles for the week of March 17, 2025.
Here are the top 5 biosimilar articles for the week of March 10, 2025.
Here are the top 5 biosimilar articles for the week of March 3, 2025.
Here are the top 5 biosimilar articles for the week of February 24, 2025.
Here are the top 5 biosimilar articles for the week of February 17, 2025.
Travis Brewer, Texas Oncology
Here are the top 5 biosimilar articles for the week of February 10, 2025.
Here are the top 5 biosimilar articles for the week of February 3, 2025.
Josh Canavan, PharmD, head of pharmacy at RazorMetrics
Related Content
© 2025 MJH Life Sciences

All rights reserved.